{
  "image_filename": "table_p11_det_10_013.png",
  "image_path": "Liu_et_al.__2024_/extracted/figures/table_p11_det_10_013.png",
  "image_type": "Table",
  "page_number": 11,
  "block_id": "det_10_013",
  "claim_id": "claim_005",
  "claim": "Flublok (quadrivalent) was evaluated in the pivotal trial against Fluarix (quadrivalent standard-dose vaccine).",
  "supports_claim": false,
  "explanation": "Table showing demographic characteristics of participants in a study comparing four influenza vaccines (Fluzone IIV4, Fluarix IIV4, ccIIV4, RIV4), including sample sizes, mean age, age group breakdown, sex, race/ethnicity, study site, and prior vaccination history. The table lists both Fluarix IIV4 and RIV4 (Flublok) arms in the same study and provides baseline demographics, but it does not identify this as the pivotal trial nor present any immunogenicity or efficacy data from a pivotal comparison; therefore, it does not support the claim Note: The table appears to be from an observational or safety study rather than a registration (pivotal) clinical trial; without explicit trial identification or endpoints, linking it to the pivotal study is uncertain.",
  "model_used": "o4-mini",
  "detailed_analysis": {
    "supports_claim": false,
    "image_description": "Table showing demographic characteristics of participants in a study comparing four influenza vaccines (Fluzone IIV4, Fluarix IIV4, ccIIV4, RIV4), including sample sizes, mean age, age group breakdown, sex, race/ethnicity, study site, and prior vaccination history.",
    "evidence_found": null,
    "reasoning": "The table lists both Fluarix IIV4 and RIV4 (Flublok) arms in the same study and provides baseline demographics, but it does not identify this as the pivotal trial nor present any immunogenicity or efficacy data from a pivotal comparison; therefore, it does not support the claim",
    "confidence_notes": "The table appears to be from an observational or safety study rather than a registration (pivotal) clinical trial; without explicit trial identification or endpoints, linking it to the pivotal study is uncertain."
  }
}